China Sinopharm’s potential COVID-19 vaccine triggers antibodies in clinical trials

C

A coronavirus vaccine candidate developed by a unit of China National Pharmaceutical Group (Sinopharm) appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials, researchers said.

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval.

Sinopharm is testing the potential vaccine in the United Arab Emirates in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site.

The state-owned company will also supply the candidate to Pakistan as part of a trial agreement, the Wall Street Journal reported.

https://www.reuters.com/article/us-health-coronavirus-vaccine-china/china-sinopharms-potential-covid-19-vaccine-triggers-antibodies-in-clinical-trials-journal-idUSKCN25A0PRHELP US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.